Invest
Is Visa a buy after surpassing estimates in quarterly results?
Visa Incorporated (NYSE:V) rose 11.6% on Friday, the largest daily gain since 2020, after posting impressive quarterly results that beat Wall Street estimates. The financial
Bill Smead: buy real estate to hedge against inflation
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Ford pauses gains ahead of fourth quarter 2021 results. What should you expect?
Ford Motor Company (NYSE:F) has dropped more than 30% in the past two weeks in a correction coming just a few days to the announcement
Basset Furniture shares are up 30% on Monday: this is why
Shares of Bassett Furniture Industries Inc (NASDAQ: BSET) are up 30% on Monday after the furniture manufacturer and retailer announced an $87 million deal with
Is BMW buy opportunity after the current dip?
Bayerische Motoren Werke AG (ETR: BMW) shares have weakened more than 6% since 14th January, and the current share price stands at €93. BMW continues
AMD stock price outlook ahead of earnings report
The Advanced Micro Devices (NASDAQ: AMD) stock price rose by more than 2.5% on Friday as tech stocks made a comeback. The stock is trading
Should I sell McDonald’s shares after Q4 results?
McDonald’s Corporation (NYSE: MCD) shares continue to trade above $250 support even though the company reported weaker than expected fourth-quarter results on Friday. Oppenheimer has
Harley Davidson shares are down 11% YTD. Should I invest?
Harley-Davidson, Inc. (NYSE: HOG) shares have weakened from $37.8 to $32.13 since the beginning of January 2022, and the current price stands at $33.74. Harley
Mizuho’s Vamil Divan reveals his top biotech pick
AbbVie Inc (NYSE: ABBV) closed 2021 with a 25% gain in the stock price, and Mizuho’s senior biopharmaceuticals research analyst says 2022 will be another
Caterpillar reports Q4 results: ‘growth at a reasonable price’
Caterpillar Inc (NYSE: CAT) on Friday said its Q4 profit and revenue topped Wall Street estimates. Shares still slipped 6.0% as the increase in costs